Investigation of a New Trial Drug (FE200486) in Prostate Cancer Patients

Clinical trial NCT00818623 · COMPLETED

Trial details

NCT number: NCT00818623
Sponsor: Ferring Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2002-11-01
Primary completion: 2004-10-01
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.